Colgate director receives 293-share stock award
Colgate-Palmolive director Lorrie M. Norrington acquired 293 shares of common stock at $89.45 per share as a grant under her compensation program.
Rhea-AI Filing Summary
Colgate-Palmolive director Lorrie M. Norrington acquired 293 shares of common stock at $89.45 per share as a grant under her compensation program. The footnote explains this represents a portion of her annual cash retainer deferred into a stock unit account under the Deferred Compensation Plan for Non-Employee Directors. Following this award, she directly holds 42,769 shares of Colgate-Palmolive common stock, indicating this is a small, routine, compensation-related transaction rather than an open-market purchase.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 293 | $89.45 | $26K |
Footnotes (1)
- F1. Portion of annual cash retainer deferred to a stock unit account pursuant to the Deferred Compensation Plan for Non-Employee Directors.
Key Figures
Key Terms
Deferred Compensation Plan for Non-Employee Directors financial
stock unit account financial
annual cash retainer financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Colgate-Palmolive (CL) director Lorrie M. Norrington report on this Form 4?
Was the Colgate-Palmolive (CL) insider transaction a market purchase or a compensation grant?
What does the footnote to Lorrie M. Norrington’s Colgate-Palmolive (CL) Form 4 transaction explain?
Does Lorrie M. Norrington’s Colgate-Palmolive (CL) Form 4 indicate any derivative or option exercises?
AI-generated analysis. How Rhea-AI works. Not financial advice.